Disebo Potloane
Dados Biográficos
| ID | 9070153 |
|---|---|
| NOME | Disebo Potloane |
| PRENOMES | Disebo |
| SOBRENOME | Potloane |
| ASSINATURA | POTLOANE D |
| AFILIAÇÕES | Centre for the AIDS Programme of Research in South Africa |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2024 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
Evaluating Motivational Interviewing and Peer Adherence Support as Strategies to Improve Oral PrEP Adherence among HIV-Negative Adults in KwaZulu-Natal, South Africa
Consistent adherence is essential for the effectiveness of daily oral pre-exposure prophylaxis (PrEP) in preventing HIV. Motivational interviewing (MI) and peer adherence support (PAS) are adherence support strategies, providing individualized support and may enhance both adherence to oral PrEP and continued use over time. This study aimed to evaluate the impact of implementation-adapted MI and PAS approaches on oral PrEP adherence and identify p…
Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa
Limited studies have been conducted on the safety and effectiveness of heterologous COVID-19 vaccine boosting in lower income settings, especially those with high-HIV prevalence., The Sisonke Heterologous mRNA-1273 boost after prime with Ad26.COV2.S (SHERPA) trial evaluated a mRNA-1273 boost after Ad26.COV2.S priming in South Africa. SHERPA was a single-arm, open-label, phase 3 study nested in the Sisonke implementation trial of 500000 healthcare…
Sem obras proeminentes nesta página.
Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa
Limited studies have been conducted on the safety and effectiveness of heterologous COVID-19 vaccine boosting in lower income settings, especially those with high-HIV prevalence., The Sisonke Heterologous mRNA-1273 boost after prime with Ad26.COV2.S (SHERPA) trial evaluated a mRNA-1273 boost after Ad26.COV2.S priming in South Africa. SHERPA was a single-arm, open-label, phase 3 study nested in the Sisonke implementation trial of 500000 healthcare…
Evaluating Motivational Interviewing and Peer Adherence Support as Strategies to Improve Oral PrEP Adherence among HIV-Negative Adults in KwaZulu-Natal, South Africa
Consistent adherence is essential for the effectiveness of daily oral pre-exposure prophylaxis (PrEP) in preventing HIV. Motivational interviewing (MI) and peer adherence support (PAS) are adherence support strategies, providing individualized support and may enhance both adherence to oral PrEP and continued use over time. This study aimed to evaluate the impact of implementation-adapted MI and PAS approaches on oral PrEP adherence and identify p…
Adverse effect (1 obras) · Clinical endpoint (1 obras) · Clinical trial (1 obras) · COVID-19 Clinical Research Studies (1 obras) · Health psychology (1 obras) · HIV-related health complications and treatments (1 obras) · HIV/AIDS Research and Interventions (1 obras) · Immunology (1 obras) · Internal Medicine (1 obras) · Intervention (counseling) (1 obras)